Taurodeoxycholic acid

Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.

Cross Reference

Introduction

To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Taurodeoxycholic acid?

Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid

MeSH term MeSH ID Detail
Colitis, Ulcerative D003093 24 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Cholestasis D002779 23 associated lipids
Birth Weight D001724 23 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Tay-Sachs Disease D013661 2 associated lipids
Fetal Resorption D005327 15 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Taurodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Taurodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Taurodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Taurodeoxycholic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Taurodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 449
Authors Title Published Journal PubMed Link
Aguirre TAS et al. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage. 2016 J Control Release pmid:27480451
Fang ZZ et al. Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression. 2016 Toxicol. Appl. Pharmacol. pmid:26706406
Aguirre TA et al. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin. 2015 Eur J Pharm Sci pmid:26349051
James L et al. Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity. 2015 PLoS ONE pmid:26208104
Brighton CA et al. Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors. 2015 Endocrinology pmid:26280129
Chatterjee S et al. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates. 2014 Toxicol In Vitro pmid:24211540
Liu Y et al. Functional role of tlyC1 encoding a hemolysin-like protein from Bifidobacterium longum BBMN68 in bile tolerance. 2014 FEMS Microbiol. Lett. pmid:25227940
Cheng X et al. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum. 2014 J. Pharmacol. Exp. Ther. pmid:25034404
Hismiogullari AA et al. Isolation and biochemical analysis of vesicles from taurohyodeoxycholic acid-infused isolated perfused rat livers. 2013 World J. Gastroenterol. pmid:24115821
Cao W et al. Expression of bile acid receptor TGR5 in gastric adenocarcinoma. 2013 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:23238937
Asaro F et al. 23Na and 35/37Cl as NMR probes of growth and shape of sodium taurodeoxycholate micellar aggregates in the presence of NaCl. 2013 J Colloid Interface Sci pmid:23127873
Lin EP et al. On-line sample preconcentration by sweeping and poly(ethylene oxide)-mediated stacking for simultaneous analysis of nine pairs of amino acid enantiomers in capillary electrophoresis. 2013 Talanta pmid:23953474
Yang YY et al. Role of endoplasmic reticular stress in aortic endothelial apoptosis induced by intermittent/persistent hypoxia. 2013 Chin. Med. J. pmid:24286417
Heinen CA et al. Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chloride. 2013 Mol. Pharm. pmid:23750707
Mencarelli A et al. Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 2013 Diabetes pmid:23835330
Lee HK et al. Bile Acid Inhibition of N-type Calcium Channel Currents from Sympathetic Ganglion Neurons. 2012 Korean J. Physiol. Pharmacol. pmid:22416216
Renga B et al. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 2012 PLoS ONE pmid:22291955
Lodola A et al. A catalytic mechanism for cysteine N-terminal nucleophile hydrolases, as revealed by free energy simulations. 2012 PLoS ONE pmid:22389698
Schreiber R et al. Retinyl ester hydrolases and their roles in vitamin A homeostasis. 2012 Biochim. Biophys. Acta pmid:21586336
Studer E et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. 2012 Hepatology pmid:21932398
Mühlfeld S et al. Short-term feedback regulation of bile salt uptake by bile salts in rodent liver. 2012 Hepatology pmid:22806967
Perrone EE et al. Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression. 2012 J. Surg. Res. pmid:22626558
Düfer M et al. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. 2012 Diabetes pmid:22492528
Meira SM et al. Probiotic potential of Lactobacillus spp. isolated from Brazilian regional ovine cheese. 2012 J. Dairy Res. pmid:23171587
Karlgren M et al. In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions. 2012 Pharm. Res. pmid:21861202
Zhang Y et al. Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice. 2012 PLoS ONE pmid:22496825
Kumar M et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. 2012 Exp Diabetes Res pmid:22611376
Okoli AS et al. Effects of human and porcine bile on the proteome of Helicobacter hepaticus. 2012 Proteome Sci pmid:22533459
Karmakar S et al. TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis. 2012 PLoS Pathog. pmid:22511870
García-Arnandis I et al. Control of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes. 2011 PLoS ONE pmid:21961038
Ben Bacha A et al. Biochemical properties of pancreatic colipase from the common stingray Dasyatis pastinaca. 2011 Lipids Health Dis pmid:21549005
Trottier J et al. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. 2011 PLoS ONE pmid:21760958
Jing Yu V et al. Identification of components of grape powder with anti-apoptotic effects. 2011 Toxicol Ind Health pmid:20699283
Krasowski MD et al. The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. 2011 BMC Biochem. pmid:21291553
Dai J et al. Impact of bile acids on the growth of human cholangiocarcinoma via FXR. 2011 J Hematol Oncol pmid:21988803
Halin J and Mattjus P Effects of bile salts on glucosylceramide containing membranes. 2011 Biochim. Biophys. Acta pmid:21910967
Lunelli M et al. Crystal structure of PrgI-SipD: insight into a secretion competent state of the type three secretion system needle tip and its interaction with host ligands. 2011 PLoS Pathog. pmid:21829362
Ishikawa H and Watanabe S Cattle bile aggravates diclofenac sodium-induced small intestinal injury in mice. 2011 Evid Based Complement Alternat Med pmid:21584236
Dunphy DR et al. X-ray characterization of self-assembled long-chain phosphatidylcholine/bile salt/silica mesostructured films with nanoscale homogeneity. 2011 Chem. Commun. (Camb.) pmid:21135947
Bernstein C et al. Carcinogenicity of deoxycholate, a secondary bile acid. 2011 Arch. Toxicol. pmid:21267546
Zahiri HR et al. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury. 2011 Surgery pmid:21878234
Reiner JL et al. Determination of perfluorinated compounds in human plasma and serum Standard Reference Materials using independent analytical methods. 2011 Anal Bioanal Chem pmid:21912833
He J et al. Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice. 2011 Eur. J. Pharmacol. pmid:21925164
Martin NA et al. Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis. 2011 PLoS ONE pmid:22162748
Jin HT et al. Association between remote organ injury and tissue polyamine homeostasis in acute experimental pancreatitis - treatment with a polyamine analogue bismethylspermine. 2011 Pharmacol Rep pmid:22001988
Raufman JP et al. Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells. 2011 Biochem. Biophys. Res. Commun. pmid:22027145
Roberts RE et al. The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. 2011 Clin. Endocrinol. (Oxf) pmid:21039722
Ngamukote S et al. Cholesterol-lowering activity of the major polyphenols in grape seed. 2011 Molecules pmid:21694670
Kaddurah-Daouk R et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. 2011 PLoS ONE pmid:22022402
Zhang Y et al. Loss of organic anion transporting polypeptide 1a1 increases deoxycholic acid absorption in mice by increasing intestinal permeability. 2011 Toxicol. Sci. pmid:21914718